Advertisement
Advertisement
SOLV
Solventum Corporation
64.70
USDSponsored
+0.06
+0.10%
Mar 26, 15:59 UTC -4
Closed
After-Market
64.72
+0.02
+0.03%
SOLV Earnings Reports
Positive Surprise Ratio
SOLV beat 8 of 8 last estimates.
100%
Next Report
Date of Next Report
May 06, 2026
Estimate for Q1 26 (Revenue/ EPS)
$2.01B
/$1.37
Implied change from Q4 25 (Revenue/ EPS)
+0.44%
/-12.74%
Implied change from Q1 25 (Revenue/ EPS)
-3.06%
/+2.24%
Solventum Corporation earnings per share and revenue
On Feb 26, 2026, SOLV reported earnings of 1.57 USD per share (EPS) for Q4 25, beating the estimate of 1.52 USD, resulting in a 2.92% surprise. Revenue reached 2.00 billion, compared to an expected 2.00 billion, with a -0.16% difference. The market reacted with a -3.56% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 12 analysts forecast an EPS of 1.37 USD, with revenue projected to reach 2.01 billion USD, implying an decrease of -12.74% EPS, and increase of 0.44% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were Solventum Corporation's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Solventum Corporation reported EPS of $1.57, beating estimates by 2.92%, and revenue of $2.00B, -0.16% below expectations.
How did the market react to Solventum Corporation's Q4 2025 earnings?
The stock price moved down -3.56%, changed from $76.94 before the earnings release to $74.20 the day after.
When is Solventum Corporation expected to report next?
The next earning report is scheduled for May 06, 2026.
What are the forecasts for Solventum Corporation's next earnings report?
Based on 12
analysts, Solventum Corporation is expected to report EPS of $1.37 and revenue of $2.01B for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement